DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

SVB Leerink Initiates Coverage On Osmotica Pharmaceuticals with Outperform Rating, Announces $10 Price Target

SVB Leerink analyst Ami Fadia initiates coverage on Osmotica Pharmaceuticals (NASDAQ:OSMT) with a Outperform rating and a $10 price target.

Benzinga · 03/06/2020 11:53

SVB Leerink analyst Ami Fadia initiates coverage on Osmotica Pharmaceuticals (NASDAQ:OSMT) with a Outperform rating and a $10 price target.